Tramadol to blame for classics crashes says Lotto-Belisol doctor

Lotto-Belisol team doctor Jan Mathieu thinks that use of powerful painkiller Tramadol by some riders is causing spate of crashes

Crash during 2014 E3 Harelbeke
(Image credit: Watson)

Lotto-Belisol team doctor Jan Mathieu has said that the ongoing use of powerful painkiller Tramadol by some riders is a contributing factor in the recent spate of crashes in the opening classics races of 2014, and has renewed calls to have the drug banned.

Tramadol is an opioid, and like other substances in that group it causes drowsiness as a side-effect. Mathieu says that it's this that has caused riders to lose concentration and cause crashes, according to an interview published by Belgian website

Teams that have voluntarily signed up to the Movement for Credible Cycling (MPCC)'s stringent charter do not use the drug, but teams that have not signed up - including Sky, Omega Pharma-QuickStep and BMC Racing - are free to use it as it is currently not on the World Anti-Doping Agency (WADA) list of banned substances.

"Tramadol is a really strong painkiller and has a central effect," said Mathieu. "It is dangerous for your concentration and you can become addicted to it. The MPCC has asked the UCI and WADA to ban its use."

Lotto-Belisol have suffered more than most with crash-injured riders, not least with its star sprinter Andre Greipel, who will miss the rest of his spring campaign after suffering from a dislocated collarbone at Ghent-Wevelgem.

WADA added Tramadol to its 'watch list' in 2012, and is monitoring its use and abuse within sport.

In addition to Tramadol, Mathieu says that the changes in race routes and fine weather have also created bigger groups of riders reaching pinch-points and finales of races, increasing the likelihood of crashes.

Credit: Nick Bull

André Greipel suffers suspected broken collarbone at Ghent-Wevelgem

The pre-race favourite crashed heavily with eight kilometres remaining.

Thank you for reading 20 articles this month* Join now for unlimited access

Enjoy your first month for just £1 / $1 / €1

*Read 5 free articles per month without a subscription

Join now for unlimited access

Try first month for just £1 / $1 / €1